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Background
There is evidence that myocardial ischemia in patients
with diabetes mellitus is often present without the exhi-
bition of symptoms. Moreover, recent data suggests that
silent ischemia is associated with occurrence of cardiac
events and poor outcome. Aim of our study was to
determine the prognostic value of a reversible perfusion
deficit assessed by adenosine perfusion cardiac magnetic
resonance imaging (CMR) in a consecutive cohort of
diabetes mellitus patients independent of the exhibition
of clinical symptoms.
Methods
Consecutive patients with diabetes mellitus type 2 of any
duration that were referred for adenosine perfusion
CMR were screened for enrollment. It was irrelevant
whether the patients exhibited symptoms that were
likely to be of ischemic origin or not. A reversible perfu-
sion deficit was assessed by adenosine-perfusion imaging
and late gadolinium enhancement on a 1.5 T whole-
body CMR-scanner and was defined as hypoperfusion
during adenosine infusion without corresponding late
gadolinium enhancement. The primary endpoint was
defined as cardiac death, non-fatal myocardial infarction
or stroke.
Results
The study population consisted of 239 consecutive
patients with prior diagnosed diabetes mellitus. During
the follow-up period of 5.0 ± 2.1 years 33 primary end-
points occurred. Patients with an event were
significantly older (67.7 ± 8.6 years vs. 63.6 ± 10.3 years,
p = 0.02), had lower left ventricular ejection fractions
(53.9 ± 18.2% vs. 60.0 ± 15.3%, p = 0.04) and more
often a reversible perfusion deficit (21 (63.6%) vs. 57
(27.7%), p < 0.0001) than patients without. In a multi-
variate analysis, a reversible perfusion deficit was the
strongest predictor for an event with a 3.76-fold
increased risk (p = 0.0003). Whether the patients pre-
sented symptomatically at enrollment had no influence
on their particular risk and event-free survival.
Conclusions
Adenosine perfusion CMR allows excellent risk stratifi-
cation in patients with diabetes mellitus, independent of
other risk factors or the presence of ischemic symptoms.
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